Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma

doi:10.3748/wjg.v17.i11.1501

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5402)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

420

HTML

4616

Figures (1-2)

195

Tables (1-2)

171

Sum=5402

Mar 21, 2011 (publication date) through Oct 3, 2024

Times Cited of This Article

Times Cited (60)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Mar 21, 2011; 17(11): 1501-1506
Published online Mar 21, 2011. doi: 10.3748/wjg.v17.i11.1501

Full Size Figure Download Figure

Figure 2 Fluorescence in situ hybridization targeting HER-2 in gastric carcinoma specimens showing intestinal type of carcinoma without HER-2 gene amplification (A) and intestinal type of carcinoma with HER-2 gene amplification (B) (original magnification × 1000).

Citation: Yan SY, Hu Y, Fan JG, Tao GQ, Lu YM, Cai X, Yu BH, Du YQ. Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma. World J Gastroenterol 2011; 17(11): 1501-1506
URL: https://www.wjgnet.com/1007-9327/full/v17/i11/1501.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i11.1501